Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asunaprevir + Peg/Riba in Chronic Hepatitis C
NCT01030432Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of asunaprevir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Feb 2010; status: completed.
02
Drugs
asunaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01030432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01030432.